Genetic Landscape of Male Breast Cancer

Genetic Landscape of Male Breast Cancer

Male breast cancer (MBC) is now considered molecularly different from female breast cancer (FBC). Evidence from studies indicates that common genetic and epigenetic features of FBC are not shared with those diagnosed in men. Genetic predisposition is likely to play a significant role in the tumorige...

Full description

Bibliographic Details
Main Authors:	Fernando Augusto Batista Campos, Etienne Rouleau, Giovana Tardin Torrezan, Dirce Maria Carraro, José Claudio Casali da Rocha, Higor Kassouf Mantovani, Leonardo Roberto da Silva, Cynthia Aparecida Bueno de Toledo Osório, Solange Moraes Sanches, Sandrine M. Caputo, Elizabeth Santana dos Santos
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	Cancers
Subjects:	male breast cancer <i>BRCA2</i> <i>BRCA1</i> hereditary breast cancer genetic testing
Online Access:	https://www.mdpi.com/2072-6694/13/14/3535

Similar Items

Non-Coding Variants in <i>BRCA1</i> and <i>BRCA2</i> Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
by: Elizabeth Santana dos Santos, et al.
Published: (2018-11-01)

Identification of Variants (rs11571707, rs144848, and rs11571769) in the <i>BRCA2</i> Gene Associated with Hereditary Breast Cancer in Indigenous Populations of the Brazilian Amazon
by: Elizabeth Ayres Fragoso Dobbin, et al.
Published: (2021-01-01)

Differences in Ovarian and Other Cancers Risks by Population and <i>BRCA</i> Mutation Location
by: Masayuki Sekine, et al.
Published: (2021-07-01)

Breast Cancer Predisposition Genes and Synthetic Lethality
by: Hannah E. Neiger, et al.
Published: (2021-05-01)

<i>BRCA</i> Mutations and Breast Cancer Prevention
by: Joanne Kotsopoulos
Published: (2018-12-01)

No Association of Early-Onset Breast or Ovarian Cancer with Early-Onset Cancer in Relatives in <i>BRCA1</i> or <i>BRCA2</i> Mutation Families
by: Marion Imbert-Bouteille, et al.
Published: (2021-07-01)

Five Italian Families with Two Mutations in <i>BRCA</i> Genes
by: Maria Teresa Vietri, et al.
Published: (2020-12-01)

Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond <i>BRCA1/2</i>
by: Daniele Fanale, et al.
Published: (2020-08-01)

Analysis of Italian <i>BRCA1/2</i> Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy
by: Gisella Figlioli, et al.
Published: (2021-01-01)

Recurrent Germline BRCA2 Gene Mutation in Lithuanian Family
by: Ieva Sadzevičienė, et al.
Published: (2020-03-01)

GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the <i>BRCA1</i> and <i>BRCA2</i> Genes
by: Laura Caleca, et al.
Published: (2019-01-01)

Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in <i>BRCA1, BRCA2</i>, and <i>TP53</i> Genes in Women with Very Early-Onset (<36 Years) Breast Cancer
by: Zerin Hyder, et al.
Published: (2020-02-01)

Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
by: Hikmat Abdel-Razeq, et al.
Published: (2018-02-01)

A Recurrent <i>BRCA2</i> Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico
by: Hector J. Diaz-Zabala, et al.
Published: (2018-11-01)

Transcriptome Patterns of <i>BRCA1</i>- and <i>BRCA2</i>- Mutated Breast and Ovarian Cancers
by: Arsen Arakelyan, et al.
Published: (2021-01-01)

A Population-Based Analysis of <i>BRCA1</i>/<i>2</i> Genes and Associated Breast and Ovarian Cancer Risk in Korean Patients: A Multicenter Cohort Study
by: Kyung-Sun Park, et al.
Published: (2021-05-01)

Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)
by: Fatima Zahra El Ansari, et al.
Published: (2020-08-01)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior <i>BRCA1/2</i> Probability
by: D. Gareth Evans, et al.
Published: (2021-08-01)

Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in <i>BRCA1/2</i> Genes
by: Lorena Incorvaia, et al.
Published: (2020-05-01)

A Multi-Center Study of <i>BRCA1</i> and <i>BRCA2</i> Germline Mutations in Mexican-Mestizo Breast Cancer Families Reveals Mutations Unreported in Latin American Population
by: Oliver Millan Catalan, et al.
Published: (2019-08-01)

BRCA Previvors: Medical and Social Factors That Differentiate Them From Previvors With Other Hereditary Cancers
by: Campo-Engelstein, Lisa
Published: (2017-04-01)

Identification of a Splice Variant (c.5074+3A>C) of <i>BRCA1</i> by RNA Sequencing and TOPO Cloning
by: Jinyoung Hong, et al.
Published: (2021-05-01)

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
by: Christoph Engel, et al.
Published: (2018-03-01)

<i>BRCA</i> Genes and Related Cancers: A Meta-Analysis from Epidemiological Cohort Studies
by: Yen-Chien Lee, et al.
Published: (2021-08-01)

BRCA1, BRCA2 mutations — future of predictive oncology: a review of literature
by: V. N. Dmitriev, et al.
Published: (2014-07-01)

THE EFFECT OF CLINICAL PRACTICE LOCATION ON PHYSICIAN REFERRAL PRACTICES AND ATTITUDES FOR HEREDITARY BREAST CANCER
by: KREKEL, CHRISTINE ELIZABETH
Published: (2002)

<i>BRCA1/2</i> Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing
by: Ewelina Szczerba, et al.
Published: (2021-04-01)

Dealing With BRCA1/2 Unclassified Variants in a Cancer Genetics Clinic: Does Cosegregation Analysis Help?
by: Roberta Zuntini, et al.
Published: (2018-09-01)

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide
by: Yosuke Hirotsu, et al.
Published: (2020-05-01)

<i>BRCA1</i> and <i>BRCA2</i> Gene Mutations and Lung Cancer Sisk: A Meta-Analysis
by: Yen-Chien Lee, et al.
Published: (2020-04-01)

Algorithm of molecular genetic investigation to identify hereditary <i>BRCA</i>-associated breast cancer
by: G. P. Snigireva, et al.
Published: (2019-02-01)

Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers – an interventional randomized controlled multicenter trial (LIBRE-1)
by: Marion Kiechle, et al.
Published: (2017-11-01)

Bayesian assessment of the prevalence of <i>BRCA</i>-associated breast cancer in Moscow
by: A. V. Viskovatykh
Published: (2020-01-01)

Complex Characterization of Germline Large Genomic Rearrangements of the <i>BRCA1</i> and <i>BRCA2</i> Genes in High-Risk Breast Cancer Patients—Novel Variants from a Large National Center
by: Anikó Bozsik, et al.
Published: (2020-06-01)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
by: Ellen Warner
Published: (2018-11-01)

Prevalence of the <it>BRCA1 </it>founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
by: Ewald Ingrid P, et al.
Published: (2011-12-01)

Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations
by: Athanasios Pouptsis, et al.
Published: (2020-10-01)

THE IMPACT OF GENETIC COUNSELING ON CLINICAL DECISION MAKING AMONG WOMEN EVALUATED FOR HEREDITARY BREAST AND OVARIAN CANCER RISK
by: PRITZLAFF, MARY ELIZABETH
Published: (2001)

Screening for BRCA1 and BRCA2 mutations in breast cancer patients from mexico: the public health perspective Tamizaje de BRCA1 y BRCA2 en pacientes con cáncerde mama en méxico: perspectiva de la salud pública
by: Steven A Narod
Published: (2009-01-01)

BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer
by: Maxim Pilyugin, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_gi1gm67jlgc303hrab3tdu5jg0